Active Surveillance

Risks of active surveillance for men with intermediate-risk prostate cancers

Men diagnosed with slow-growing prostate tumors that likely won’t be harmful during their lifetimes can often avoid immediate treatment. Instead, they can have their tumor monitored using a strategy called active surveillance. With this approach, doctors perform periodic checks for tumor progression and start treatment only if the cancer begins to metastasize, or spread. Active […]

Read more »

Active surveillance is safe for low-risk prostate cancers

A new study confirms that active surveillance is a safe and reasonable alternative to immediate treatment for prostate cancer. In recently published study that followed 1,300 men, the prostate cancer survival rate after 10-15 years of active surveillance, was 99%. For some men, a strong discomfort with “living with cancer” may steer them away from postponing treatment in favor of careful monitoring.

Read more »

Following low-risk prostate cancers before starting treatment becoming more common

Treatment decisions are complicated for men with low-risk prostate cancer that grows slowly. These cancers may never become deadly during a man’s expected lifespan. And there is no conclusive evidence showing that treatment in these cases extends survival. So cancer specialists have been leaning toward monitoring low-risk prostate cancer carefully and starting treatment only when it begins to spread. This approach was once used only in academic cancer centers, but new research suggests that this strategy is becoming more common in urology practices throughout the United States and other countries as well.

Read more »

How to monitor prostate cancer using active surveillance

Read more »

A patient’s story: Why one man opted for lifestyle changes instead of treatment

Patient Ben Hunter explains why he decided to postpone treatment for prostate cancer and the lifestyle changes he made immediately following his diagnosis.

Read more »

Choosing — and sticking with — active surveillance: A patient’s story

Patient Jeffrey Caruso explains why he decided to pursue active surveillance and under what circumstances he would opt to treat his prostate cancer.

Read more »

Radical prostatectomy vs. watchful waiting

Results from an ongoing trial suggest that there isn’t much difference in survival rates among men who choose surgery over watchful waiting.

Read more »

When to consider active surveillance

Which men are candidates for active surveillance? Some studies suggest that men with low risk cancer should consider active surveillance over traditional treatment, but the evidence is mixed.

Read more »